Financial Performance - Revenue for the three months ended September 30, 2022, was RMB 38,594,000, a decrease of 49% compared to RMB 75,710,000 for the same period in 2021[4] - Gross profit for the nine months ended September 30, 2022, was RMB 20,894,000, down 57.6% from RMB 49,332,000 in the same period of 2021[4] - The company reported a loss before tax of RMB 7,765,000 for the nine months ended September 30, 2022, compared to a profit of RMB 13,704,000 in the same period of 2021[4] - The total comprehensive loss for the three months ended September 30, 2022, was RMB 2,980,000, compared to a comprehensive income of RMB 569,000 for the same period in 2021[4] - The company’s basic and diluted loss per share for the nine months ended September 30, 2022, was RMB 1.04, compared to earnings of RMB 1.26 per share in the same period of 2021[4] - The company's revenue for the nine months ended September 30, 2022, was approximately RMB 182,495,000, a decrease of about RMB 40,230,000 or 18.1% compared to RMB 222,726,000 in the same period of 2021[25] - Revenue from the sale of inflatable products and related accessories for the three months ended September 30, 2022, was RMB 38,605,000, down from RMB 75,710,000 in the same period of 2021, representing a decrease of approximately 48.9%[13] - The gross profit for the nine months ended September 30, 2022, was approximately RMB 20,894,000, a decrease of about RMB 28,438,000 or 57.7% compared to RMB 49,332,000 in the same period of 2021[28] - The gross margin for the three months ended September 30, 2022, was approximately 11.5%, down from 22.1% in the same period of 2021, reflecting a decrease of about 10.6 percentage points[28] - The company recorded a net loss attributable to owners of the company of RMB (8,347,000) for the nine months ended September 30, 2022, compared to a profit of RMB 10,077,000 in the same period of 2021[21] - The company reported a loss of approximately RMB 8,347,000 for the period, a decrease of about RMB 18,424,000 or 182.8% compared to a profit of RMB 10,077,000 in the corresponding period of 2021[34] Other Income and Expenses - Other income and gains for the three months ended September 30, 2022, increased to RMB 3,691,000 from RMB 320,000 in the same period of 2021[4] - Other income and gains totaled approximately RMB 7,454,000 for the nine months ended September 30, 2022, an increase of about RMB 8,526,000 or 795% compared to RMB 1,072,000 in the same period of 2021, primarily due to foreign exchange gains of RMB 5,055,000[30] - The company’s financing costs for the nine months ended September 30, 2022, were RMB 1,231,000, a decrease from RMB 1,480,000 in the same period of 2021[4] - Distribution and selling expenses for the nine months ended September 30, 2022, were approximately RMB 19,687,000, a decrease of about RMB 2,045,000 or 9.4% compared to RMB 21,732,000 in the same period of 2021[31] - Administrative expenses increased to approximately RMB 15,195,000 for the nine months ended September 30, 2022, up by about RMB 1,707,000 or 12.66% from RMB 13,488,000 in the same period of 2021[32] Equity and Dividends - The total equity attributable to owners of the company as of September 30, 2022, was RMB 114,147,000, down from RMB 121,906,000 as of January 1, 2022[5] - The company did not recommend any interim dividend for the nine months ended September 30, 2022, consistent with the previous year[22] - The board of directors did not recommend any interim dividend for the period, consistent with the previous year[35] Corporate Governance and Compliance - The audit committee, consisting of three independent non-executive directors, has reviewed the financial results and confirmed compliance with applicable accounting standards and GEM listing rules[50] - The company has adhered to the corporate governance code as per GEM listing rules during the period[49] Future Plans - The company plans to expand into healthcare services, including dental clinics and health management services[9] - The company plans to collaborate with local governments and professional organizations in the oral care industry to establish an innovative oral care service platform, aiming to drive future business performance[24] Shareholder Information - As of September 30, 2022, Ms. Yan Ping holds 424,560,000 shares, representing 53.07% of the company's ordinary shares[38] - The company has not granted any stock options under the stock option plan adopted on November 15, 2017, up to the report date[43] - The company did not engage in any purchases, sales, or redemptions of its securities during the period[46] Capital Raising Activities - On October 21, 2022, the company entered into a placement agreement to issue up to 160,000,000 new shares at a price of HKD 0.260 per share, representing approximately 16.67% of the enlarged issued share capital[47] - The net proceeds from the placement, after deducting expenses, are approximately HKD 40,520,000, intended for investment in potential dental clinics in Guangdong and for working capital[47] Investments and Acquisitions - There were no significant investments, acquisitions, or disposals of subsidiaries, associates, or joint ventures during the period, and no plans for major investments or capital assets as of September 30, 2022[36]
中国口腔产业(08406) - 2022 Q3 - 季度财报